These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


167 related items for PubMed ID: 6301062

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Combination chemotherapy with cisplatin, etoposide, and vindesine in non-small cell lung carcinoma: a clinical trial of the EORTC lung cancer working party.
    Klastersky J, Sculier JP, Nicaise C, Weerts D, Mairesse M, Libert P, Rocmans P, Michel J, Ferremans W.
    Cancer Treat Rep; 1983; 67(7-8):727-30. PubMed ID: 6347374
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Treatment of non-small-cell bronchial carcinoma with cisplatin, ifosfamide, vindesine and VP 16].
    Drings P, Manke HG.
    Strahlentherapie; 1985 Mar; 161(3):131-3. PubMed ID: 2983459
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Vindesine in bronchogenic carcinoma: a phase II trial.
    Vogelzang NJ, Peterson BA, Kennedy BJ, Vosika GJ, Conroy JA.
    Am J Clin Oncol; 1982 Feb; 5(1):41-4. PubMed ID: 6282107
    [Abstract] [Full Text] [Related]

  • 11. [Treatment of non-small cell bronchial cancer with high-dosage cisplatin and vindesine. Results of a prospective study].
    König HJ, Arnold E, Walter M, Sander U.
    Fortschr Med; 1984 Sep 06; 102(33):811-4. PubMed ID: 6090286
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Combination chemotherapy of advanced non-oat cell carcinoma of the lung.
    Richards F, White DR, Muss HB, Jackson DV, Stuart JJ, Cooper MR, Rhyne L, Spurr CL.
    Cancer; 1979 Nov 06; 44(5):1576-81. PubMed ID: 227571
    [No Abstract] [Full Text] [Related]

  • 16. Vindesine and high-dose cisplatin in the treatment of advanced non-small-cell lung cancer.
    Fuks JZ, Patel H, Van Echo DA, Hornedo J, Aisner J.
    Med Pediatr Oncol; 1985 Nov 06; 13(2):73-7. PubMed ID: 4039026
    [Abstract] [Full Text] [Related]

  • 17. Cisplatin and etoposide combination in the treatment of bronchogenic carcinoma.
    Mazzei T, Marino C, Nozzoli F, Lopes-Pegna A, Righi R, Santomaggio C, Lamanna S, Periti P.
    Chemioterapia; 1984 Feb 06; 3(1):16-8. PubMed ID: 6100172
    [Abstract] [Full Text] [Related]

  • 18. Four-drug combination chemotherapy in extensive non-small cell lung cancer: a Southwest Oncology Group Pilot Study.
    Livingston RB, Mira J, O'Bryan RM.
    Cancer Treat Rep; 1981 Feb 06; 65(1-2):143-4. PubMed ID: 6164484
    [No Abstract] [Full Text] [Related]

  • 19. New agents in non-small cell lung cancer.
    Joss RA, Cavalli F, Goldhirsch A, Mermillod B, Brunner KW.
    Cancer Treat Rev; 1984 Sep 06; 11(3):205-36. PubMed ID: 6395953
    [No Abstract] [Full Text] [Related]

  • 20. [Cis-dichlorodiammineplatinum, adriamycin and cyclophosphamide versus cis-dichlorodiammineplatinum, adriamycin, cyclophosphamide and CCNU in non-small cell carcinoma of the lung].
    Sanz Ortiz J, Saiz García F.
    Med Clin (Barc); 1984 Sep 06; 79(9):403-6. PubMed ID: 6296560
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.